table of content
1 Study Coverage
1.1 Insomnia Treatment Drugs Revenue in Insomnia Treatment Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Insomnia Treatment Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Insomnia Treatment Drugs Market Size for the Year 2017-2028
1.2.2 Global Insomnia Treatment Drugs Market Size for the Year 2017-2028
1.3 Insomnia Treatment Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Insomnia Treatment Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Insomnia Treatment Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Insomnia Treatment Drugs Market Dynamics
1.4.1 Insomnia Treatment Drugs Industry Trends
1.4.2 Insomnia Treatment Drugs Market Drivers
1.4.3 Insomnia Treatment Drugs Market Challenges
1.4.4 Insomnia Treatment Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Insomnia Treatment Drugs by Type
2.1 Insomnia Treatment Drugs Market Segment by Type
2.1.1 Prescription Sleep Aids
2.1.2 Over the Counter (OTC) Sleep Aids
2.2 Global Insomnia Treatment Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Insomnia Treatment Drugs Market Size by Type (2017-2028)
2.4 United States Insomnia Treatment Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Insomnia Treatment Drugs Market Size by Type (2017-2028)
3 Insomnia Treatment Drugs by Application
3.1 Insomnia Treatment Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Pharmacy
3.1.3 Others
3.2 Global Insomnia Treatment Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Insomnia Treatment Drugs Market Size by Application (2017-2028)
3.4 United States Insomnia Treatment Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Insomnia Treatment Drugs Market Size by Application (2017-2028)
4 Global Insomnia Treatment Drugs Competitor Landscape by Company
4.1 Global Insomnia Treatment Drugs Market Size by Company
4.1.1 Top Global Insomnia Treatment Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Insomnia Treatment Drugs Revenue by Player (2017-2022)
4.2 Global Insomnia Treatment Drugs Concentration Ratio (CR)
4.2.1 Insomnia Treatment Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Insomnia Treatment Drugs in 2021
4.2.3 Global Insomnia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Insomnia Treatment Drugs Headquarters, Revenue in Insomnia Treatment Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Insomnia Treatment Drugs Headquarters and Area Served
4.3.2 Global Insomnia Treatment Drugs Companies Revenue in Insomnia Treatment Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Insomnia Treatment Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Insomnia Treatment Drugs Market Size by Company
4.5.1 Top Insomnia Treatment Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Insomnia Treatment Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Insomnia Treatment Drugs Market Size by Region
5.1 Global Insomnia Treatment Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Insomnia Treatment Drugs Market Size by Region (2017-2028)
5.2.1 Global Insomnia Treatment Drugs Market Size by Region: 2017-2022
5.2.2 Global Insomnia Treatment Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Insomnia Treatment Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Insomnia Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Insomnia Treatment Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Insomnia Treatment Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Insomnia Treatment Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Insomnia Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Insomnia Treatment Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Insomnia Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Insomnia Treatment Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Insomnia Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 F.Hoffman La-Roche AG
7.1.1 F.Hoffman La-Roche AG Company Details
7.1.2 F.Hoffman La-Roche AG Business Overview
7.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Introduction
7.1.4 F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.1.5 F.Hoffman La-Roche AG Recent Development
7.2 Merck & Co. Inc.
7.2.1 Merck & Co. Inc. Company Details
7.2.2 Merck & Co. Inc. Business Overview
7.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Introduction
7.2.4 Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.2.5 Merck & Co. Inc. Recent Development
7.3 Mylan N.V.
7.3.1 Mylan N.V. Company Details
7.3.2 Mylan N.V. Business Overview
7.3.3 Mylan N.V. Insomnia Treatment Drugs Introduction
7.3.4 Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.3.5 Mylan N.V. Recent Development
7.4 Pfizer, Inc.
7.4.1 Pfizer, Inc. Company Details
7.4.2 Pfizer, Inc. Business Overview
7.4.3 Pfizer, Inc. Insomnia Treatment Drugs Introduction
7.4.4 Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.4.5 Pfizer, Inc. Recent Development
7.5 Pernix Therapeutics
7.5.1 Pernix Therapeutics Company Details
7.5.2 Pernix Therapeutics Business Overview
7.5.3 Pernix Therapeutics Insomnia Treatment Drugs Introduction
7.5.4 Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.5.5 Pernix Therapeutics Recent Development
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Company Details
7.6.2 Sanofi S.A. Business Overview
7.6.3 Sanofi S.A. Insomnia Treatment Drugs Introduction
7.6.4 Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.6.5 Sanofi S.A. Recent Development
7.7 Takeda Pharmaceutical Company Ltd.
7.7.1 Takeda Pharmaceutical Company Ltd. Company Details
7.7.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Introduction
7.7.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.7.5 Takeda Pharmaceutical Company Ltd. Recent Development
7.8 Sumitomo Dainippon Pharma Co., Ltd
7.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
7.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
7.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Introduction
7.8.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Company Details
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Introduction
7.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.10 Vanda Pharmaceuticals, Inc.
7.10.1 Vanda Pharmaceuticals, Inc. Company Details
7.10.2 Vanda Pharmaceuticals, Inc. Business Overview
7.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Introduction
7.10.4 Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2017-2022)
7.10.5 Vanda Pharmaceuticals, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
